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Objectives. Hypertension, if uncontrolled, can lead to hypertensive crisis. We aim to determine the prevalence of hypertensive
crisis, its management, and outcome in patients presenting to a tertiary care center in Karachi. Methods. This was a cross-sectional
study conducted at the Aga Khan University, Karachi, Pakistan. Adult inpatients (>18 yrs) presenting to the ER who were known
hypertensive and had uncontrolled hypertension were included. Results. Out of 1336 patients, 28.6% (387) had uncontrolled
hypertension. The prevalence of hypertensive crisis among uncontrolled hypertensive was 56.3% (218). Per oral calcium channel
blocker; 35.4% (137) and intravenous nitrate; 22.7% (88) were the most commonly administered medication in the ER. The mean
(SD) drop in SBP in patients with hypertensive crisis on intravenous treatment was 53.1 (29) mm Hg and on per oral treatment was 43
(27) mm Hg. The maximum mean (SD) drop in blood pressure was seen by intravenous sodium nitroprusside; 80 (51) mm Hg in SBP.
Acute renal failure was the most common complication with a prevalence of 11.5% (24). Conclusion. The prevalence of hypertensive
crisis is high. Per oral calcium channel blocker and intravenous nitrate are the most commonly administered medications in our
setup.

1. Background
Hypertension is a common chronic medical condition affecting people in Pakistan and the rest of the world [1]. It
is an important modifiable risk factor for cardiovascular
morbidity and mortality, particularly for stroke (accounting
for 51% of all stroke deaths worldwide), ischemic heart disease
(45% of all deaths), chronic kidney disease, congestive heart
failure, aortic aneurysm, and peripheral arterial disease [2].
Prevalence of hypertension (systolic blood pressure >140 mm
Hg or diastolic blood pressure >90 mm Hg, or on antihypertensive medications) in Pakistan has increased from 17% in
1980 to 35% in 2008 in adults aged 18 years and older [3].
The increasing prevalence of hypertension together with a
deficient control makes this one of the frequent conditions
that require urgent medical attention [4].
The prevalence of uncontrolled hypertension varies
around the world, with the lowest prevalence in rural India
(3.4% in men and 6.8% in women) and the highest prevalence

in Poland (68.9% in men and 72.5% in women) [5]. Recent
population based data for control rates of hypertension
from Pakistan are not available. However, the control of
hypertension was 23% from a community based data in
urban population from Karachi, Pakistan [6]. Uncontrolled
hypertension can progress to hypertensive crisis defined as
a systolic blood pressure >180 mm Hg or a diastolic blood
pressure >120 mm Hg [7]. Hypertensive crisis can be further classified as a hypertensive urgency or hypertensive
emergency depending on end-organ involvement including
cardiac, renal, and neurologic injury. “Hypertensive urgency”
refers to severe hypertension without evidence of new or
worsening end-organ injury while “Hypertensive emergency”
refers to a severe hypertension that is associated with new or
progressive end-organ damage [8].
Hypertensive crises (76% urgencies, 24% emergencies)
represented more than one-fourth of all medical urgencies/emergencies. Hypertensive urgencies frequently present
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with headache (22%), epistaxis (17%), and psychomotor agitation (10%) and hypertensive emergencies frequently present
with chest pain (27%), dyspnea (22%), and neurological
deficit (21%) [9]. The reason for uncontrolled hypertension in
Pakistan is high due to lack of awareness, knowledge, adherence, and attitudes of Pakistani patients with hypertension
[10]. However there is no data on patients with hypertensive
crisis from tertiary care hospitals in Pakistan. Additionally
the number of patients who complicate towards stroke,
myocardial infarction, and chronic kidney disease is also not
known. Hence, it is essential to have figures on prevalence and
clinical presentation from our setup. Therefore, we conducted
this study to determine the prevalence of hypertensive crisis,
its management, and its outcome in patients presenting to a
tertiary care center in Karachi.

2. Methods
2.1. Study Design and Study Population. This was a retrospective study conducted at the Aga Khan University, Karachi,
Pakistan. The Aga Khan University Hospital (AKUH) has 563
beds in operation and provides services to over 50,000 hospitalized patients and to over 600,000 outpatients annually.
Ethical approval from the ethics review committee of the Aga
Khan University (1985-Med-ERC-11) was taken for conduct
of the study.
Adult inpatients (>18 yrs) presenting to the ER who were
known hypertensive and had uncontrolled hypertension were
included. Controlled blood pressure was defined as systolic
blood pressure (SBP) <140 mm Hg or diastolic blood pressure
(DBP) <90 mm Hg [11]. Uncontrolled hypertension was
defined as SBP >140 mm Hg and DBP >90 mm Hg in both
diabetic and nondiabetic patients who were either aware of
their problem or under pharmacological treatment [12]. The
sample was drawn using computerized medical record system
International Classification of Diseases-9-Coordination and
Maintenance (ICD-9-CM) at health information management system in the hospital. Patients admitted with primary
diagnosis of hypertension crisis, uncontrolled hypertension,
hypertensive emergency, and hypertensive urgency were
selected through the ICD-9-CM (I-10: essential (primary)
hypertension, I-11: hypertensive heart disease, I-12: hypertensive renal disease, I-13: hypertensive heart and renal disease,
and I-15: secondary hypertension). Patients whose medical
records did not contain minimal clinical information to
allow case classification (hypertensive urgency or emergency)
were excluded from the study [13]. Data over a period of
5 years, from year 2005 till year 2010, was used. A sample
of 1336 consecutive patients fulfilling the inclusion criterion
was selected. All patients gave a general consent on admission; however informed consent was not taken as data was
extracted later through ICD-9-CM.
2.2. Study Variables and Measurements. Data on demographics, comorbid conditions, clinical symptoms, blood pressure
readings at subsequent time intervals, length of stay, and
antihypertensive drug therapy was recorded by trained data
collectors. Age and gender were recorded as mentioned at the
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time of admission. A history of physician-diagnosed diabetes
mellitus (DM), chronic kidney disease (CKD), ischemic heart
disease (IHD), and stroke was noted from the patient’s
medical record file. DM was defined as fasting plasma glucose
≥126 mg/dL at a prior visit [14]. CKD was defined as rise in
serum creatinine of >1.2 mg/dL for 3 months [15]. IHD was
diagnosed using WHO definition [16]. Clinical symptoms
were recorded from the physician’s initial assessment sheet.
Blood pressure readings, at different time intervals, were
recorded from vital sheets for nursing services. Blood pressure was measured using a mercury sphygmomanometer
with the patient in sitting position. Hypertensive crisis was
defined as a systolic blood pressure >180 mm Hg or a diastolic
blood pressure >120 mm Hg [7]. Management of patient
was assessed by recording the list of medication from the
computer generated pharmacy sheet attached inside the
medical record file. Antihypertensive treatment was divided
into two types: medication given per oral and medications
given intravenously. Troponin-I values where available were
recorded using the Patient Profile Viewer, an online hospital
database software.
Outcome of patient was assessed in terms of length of
stay and complications. Mean length of stay was recorded by
calculating the time interval between the patient’s admission
date/time and discharge date/time from ER/ward. Various
complications like myocardial infarction, stroke, aortic dissection, acute renal failure, and pulmonary edema developed
during the hospital stay were recorded using the discharge
summary notes filled by the primary consultant. Myocardial
infarction was diagnosed when blood levels of sensitive and
specific biomarkers such as cardiac troponin or CKMB are
increased in the clinical setting of acute myocardial ischemia
with electrocardiographic changes [17]. According to WHO
definition, stroke was defined as a rapidly developing clinical sign of focal (at times global) disturbance of cerebral
function, lasting more than 24 hours or leading to death
with no apparent cause other than that of vascular origin
[18]. Aortic dissection was referred as the condition when a
separation has occurred in aortic wall intima as diagnosed
on CT scan, causing blood flow into a new false channel
composed of the inner and outer layers of the media [19].
Acute renal failure was diagnosed when the plasma urea
nitrogen (PUN) or serum creatinine did not stabilize within
72 hours [20]. Acute pulmonary edema was defined as alveolar or interstitial edema verified by chest X-ray and/or with
O2 saturation <90% on room air prior to treatment accompanied by severe respiratory distress, with crackles over
the lungs and orthopnea [21]. A minimum sample size of
237 patients was required to estimate a proportion of 19%
of patients with hypertensive crises presenting to ER, with
bound on error of 5% and alpha of 5%.
2.3. Statistical Methods. Data was analyzed using Statistical
Package of Social Sciences (SPSS) version 19.1. Mean and
standard deviation were used for qualitative variables and
frequency and percentage for qualitative variables. Chisquare test was used to compare categorical variables and
Student’s t-test was used to compare quantitative variables.
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Table 1: Baseline characteristics of patients overall, with hypertensive crisis and without hypertensive crisis (𝑁 = 387).
Characteristics
Mean age (SD)
Male gender
Smoking
Dyslipidemia
Diabetes mellitus
Ischemic heart disease
Cerebrovascular accident
∗

Overall
𝑁 = 387
𝑁 (%)
56.72 (14.78)
175 (45.2)
54 (14.0)
167 (43.2)
143 (37.0)
83 (21.4)
26 (6.7)

Hypertensive crisis
𝑁 = 218 (56.3)
𝑁 (%)
55.92 (15.09)
89 (41)
34 (15.6)
87 (39.9)
77 (35.3)
34 (15.6)
14 (6.4)

No hypertensive crisis
𝑁 = 169 (43.7)
𝑁 (%)
57.75 (14.36)
86 (50.6)
20 (11.8)
80 (47.3)
66 (39.1)
49 (29)
12 (7.1)

𝑃 value∗
0.22
0.03
0.18
0.08
0.25
0.001
0.47

𝑃 value < 0.05 was taken as significant; it is calculated for hypertensive crisis and no hypertensive crisis.

3. Results
3.1. Baseline Characteristics of Patients. A total of 73,063
hypertensive patients presented to the ER between years 2005
and 2010 out of which a sample of 1336 (1.8%) patients was
taken for this study. The prevalence (%) of uncontrolled
hypertension was 28.9% (387). Prevalence of hypertensive
crisis overall was 16.3% (218) and among those with uncontrolled hypertension is 56.3% (218). Mean age (SD) of patients
presenting to the ER was 56.7 (14.7) and 175% (45.2) of
patients were male. Overall, dyslipidemia was the most common comorbidity in patients presenting with uncontrolled
hypertension to the ER with the prevalence of 43.2% (167)
followed by diabetes mellitus, 36.9% (143), and ischemic heart
disease, 21.4% (83), and 13.9% (54) of them were smokers. The
baseline characteristics of patients overall, with hypertensive
crisis and without hypertensive crisis, are given in Table 1.
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3.2. Clinical Characteristics of Patients. Headache was the
most common presenting symptom, 35.7% (138), followed
by dyspnea, 32.6% (126), chest pain, 21.4% (83), dizziness,
21.2% (82), vomiting, 17.3% (67), epistaxis, 5.2% (20), and
neurologic deficit, 3.6% (14). On comparison of patients with
hypertensive crisis with those with no hypertensive crisis the
clinical symptoms that were statistically significant were as
follows: headache was present in 42.2% (92) versus 27.2% (46)
𝑃 value = 0.002 and chest pain was present in 17.4% (38) versus
26.6% (45) 𝑃 value = 0.02.
Blood Pressure Trends of Patients with Hypertensive Crisis and
without Hypertensive Crisis. The mean (SD) systolic blood
pressure (SBP) recorded in patients with hypertensive crisis
versus no hypertensive crisis in ER was 202 (17.971) and 158
(13.387) (𝑃 value ≤ 0.001). The mean (SD) diastolic blood
pressure in patients with hypertensive crisis versus no hypertensive crisis in ER was 108 (17.429) mm Hg and 87 (14.984)
mm Hg, respectively, (𝑃 value ≤ 0.001). The trend of blood
pressure recorded in the ER is shown in Figures 1 and 2.
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Figure 1: Trend of systolic blood pressure in ER.
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Figure 2: Trend of diastolic blood pressure in ER.
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Table 2: Comparison of blood pressure in patients with and without hypertensive crisis on intravenous and per oral medications.

SBP 0∗
SBP discharge∗∗
Drop in SBP∗∗∗
DBP 0
DBP discharge
Drop in DBP

PO
Mean (SD)
𝑁 = 86
195 (17)
151 (27)
43 (27)
103 (15)
85 (19)
17.8 (22)

Hypertensive crisis
𝑁 = 218
IV
Mean (SD)
𝑁 = 130
207 (17)
154 (23)
53.1 (29)
111 (17)
85 (16)
25.8 (19)

𝑃 value
<0.001
0.56
0.01
0.001
0.93
0.006

PO
Mean (SD)
𝑁 = 118
156 (14)
141 (19)
15 (21)
87 (15)
77 (11)
9.6 (a6)

No hypertensive crisis
𝑁 = 169
IV
Mean (SD)
𝑁 = 51
162 (10)
144 (19)
17.6 (21)
88 (14)
79 (14)
9.3 (15)

𝑃 value
0.01
0.31
0.49
0.62
0.46
0.90

∗

SBP 0 is systolic blood pressure on admission to ER, ∗∗ SBP discharge was systolic blood pressure at discharge from ER or shifting to ward, and ∗∗∗ drop in
SBP was SBP on admission to ER-SBP at discharge from ER.

Table 3: Mean drop in systolic and diastolic blood pressure in ER in patients with hypertensive crisis according to type of intravenous
medication.
Intravenous medication
No IV medication
Nitrate
Sodium nitroprusside
Labetalol
Hydralazine
Beta blocker
∗

Mean (SD) drop in SBP∗
𝑁 = 218
43.16 (27.9)
58.86 (29.5)
80 (15.5)
50.62 (29.2)
48.18 (30.1)
45.21 (25.7)

𝑃 value∗∗

Mean (SD) drop in DBP

𝑃 value
0.009

0.03

17.54 (22.42)
29.86 (22.48)
37.50 (7.77)
27.11 (17.42)
18.50 (16.15)
18.71 (17.95)

Drop in SBP was SBP on admission to ER-SBP at discharge from ER.
𝑃 value is for comparison among the different intravenous medications.

∗∗

most widely used oral antihypertensive medication in the ER,
35.4% (137). Intravenous (IV) nitrate was the most commonly
administered IV medication in ER, 22.7% (88). The mean
(SD) drop in SBP in patients with hypertensive crisis who
received intravenous medications versus oral medications
was 53.1 (29) mm hg and 43 (27), respectively (𝑃 value =
0.01). The mean drop in DBP in patients with hypertensive
crisis who received intravenous versus perioral medications
was 25.8 (19) and mm hg and 17.8 (22) mm Hg, respectively
(𝑃 value = 0.006). Comparison of blood pressure trends in
patients with and without hypertensive crisis on intravenous
or per oral medication is shown in Table 2. The maximum
drop in systolic blood pressure and diastolic blood pressure
was achieved by sodium nitroprusside: 80 (15) mm Hg and
37.5 (7.77) mm Hg. Types of intravenous medications and
drop in SBP and DBP are shown in Table 3.
3.4. Outcome of Patients with Hypertensive Crisis
3.4.1. Length of Stay. The total length of stay (in days) for
patients with hypertensive crisis was 2.46 (0.164) whereas the
total length of stay (in days) for patients without hypertensive
crisis was 2.20 (0.158).
3.4.2. Complications. Overall prevalence (%) of complications was 47.7% (104) in patients with hypertensive crisis.
Acute renal failure was the most common complication with

the prevalence (%) of 41.3% (43) followed by myocardial
infarction 28.8% (30) and pulmonary edema 18.26% (19).
Stroke accounted for 6.5% (12) of complications. On comparison of patients with hypertensive crisis and patients without
it, myocardial infarction occurred in 7.2% (15) versus 9% (15),
stroke occurred in 2.4% (5) versus 4.2% (7), and acute kidney
injury occurred in 11.5% (24) versus 11.4% (19) patients,
respectively.
On further categorization of patients with hypertensive
crisis who received intravenous antihypertensive in ER versus
not receiving intravenous medication, there was no significant difference in the complications in both groups.

4. Discussion
We have shown in this study on patients presenting to ER with
hypertensive crisis that the prevalence of hypertensive crisis
is high (56.3%). Headache was the most common symptom
in patients presenting with this condition. The most potent
intravenous medication for dropping blood pressure was
sodium nitroprusside. Mean length of stay was longer in
patients with hypertensive crisis and acute renal failure was
the most common complication in these patients.
Our study showed a prevalence of hypertensive crisis of
56%. The incidence of hypertensive crisis was 47.22% in a
study conducted in Bosnia and 16% in a study conducted in
Brazil [22, 23]. This indicates that we see more hypertensive
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crisis compared to the above studies. The reasons for high
prevalence of patients with hypertensive crisis in our setup are
multiple. Lack of knowledge about control of hypertension
and poor compliance to antihypertensive medications is a
major issue in Pakistan [10]. Also, lack of proper health infrastructure in public sector leading to inability of the poor population to access healthcare adds onto the severity of hypertension in these patients [24].
In previous studies [25, 26], the most frequent clinical
sign of patients presenting to the ER was headache (22% and
42%) and dizziness was reported among 30% of emergency
department patients [25]. This study showed (36%) headache
as the most common clinical sign followed by dizziness
(21%) which supports the previous findings about the characteristics of hypertensive crisis patients. Complications of
hypertensive crisis reported in previous studies conducted
in Bahrain and Italy were acute coronary syndrome (32%),
left ventricular heart failure (38%), and stroke (29.3%) [27]
and cerebral infarction (24%), pulmonary edema (23%),
and hypertensive encephalopathy (16%) [26]. However acute
renal failure, myocardial infarction, and pulmonary edema
are the most common complications in our setup. The reason
for high prevalence of acute renal failure in our setup may be
the higher number of patients with hypertensive emergency.
The most common intravenous medication used to control hypertensive crisis in this study was nitrates. Recommendation for use of intravenous nicardipine was reported by a
study conducted in 2005 [28] whereas sodium nitroprusside,
because of its direct vasodilator effect and immediate onset
of action, was recommended for hypertensive emergency in
a subsequent study in 2006 [29]. We observed in this study
that sodium nitroprusside was the most potent intravenous
antihypertensive in dropping blood pressure. However it
was not the most commonly used drug in this study. In a
similar study, intravenous labetalol was reported as the most
frequently used antihypertensive medication for emergency
department patients presenting with hypertensive urgency
[25]. This indicates that the use of intravenous nitrate as the
most common antihypertensive for management of hypertensive crisis (apart from use in patients with cardiac cause)
is not completely in accordance with the recommendations.
The most common oral antihypertensive used in our setup
is calcium channel blocker. However in some studies, oral
labetalol [25], beta blockers, diuretics, ACE inhibitors, and
calcium channel blockers have been recommended [29]. Calcium channel blockers have also been found to be the most
common antihypertensives used for management of hypertensive in this population and have been found to have good
control rates [30]. Calcium channel is now recommended as
a first line antihypertensive in the recent NICE guidelines
[31]. Hence, management with oral antihypertensives is in
accordance with the recommendations.
The reduction in systolic and diastolic blood pressure
reported in our study shows a smooth decline in order to
avoid risks of potential side effects of a much rapid decline.
It is recommended that the initial reduction in mean arterial
pressure (MAP) in case of hypertensive emergency should
not be more than 20%–25% below the pretreatment blood
pressure or that MAP be reduced within the first 30–60
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minutes to 110–115 mm Hg [32]. This can be comparable to
our study which reported an overall decrease of blood pressure of about 52 mm Hg in SBP from intravenous medication
from the time of admission until 2 hours after admission
in ER. A rapid decline in blood pressure is associated with
acute deterioration in renal function, ischemic, cardiac, or
cerebral events, and occasional retinal artery occlusion and
acute blindness. The goal is to reduce BP by 10–15% over a
period of 30–60 minutes, with the exception of the patient
that presents with aortic dissection or acute intracranial
bleed [33]. However treatment should be individualized to
each patient based on the type and extent of end-organ
damage, degree of BP elevation, and the specific side effects
that each medication could have on a patient’s preexisting
comorbidities [34].
The strength of this study is that it is the first study from
this region to report figures on prevalence of hypertensive
crisis, as well as prevalence of complications as a result
of hypertensive crisis among patients. Moreover, this study
also reports management of these patients in terms of the
treatment received in the ER and into the ward and their
mean length of stay. However there are limitations in this
study; firstly it has limited external validity as the sample
is not representative for an entire population. It represents
population visiting a single-tertiary care hospital and, hence,
it is not representative of the entire population of Pakistan.
Secondly, compliance issues with the medication regimen
have not been taken into consideration; hence, the medications administered to the patients may be misjudged. Thirdly,
some patients may also have gotten discharged against medical advice; hence, the optimal length of stay for these patients
may not have been achieved. Fourth, this retrospective
study cannot strongly give a cause and effect association
and we have not reported the hypertensive urgencies and
emergencies separately. We did not report data separately on
hypertensive emergency and urgency and retinopathy could
not be examined and reported in all patients.

5. Conclusion
The prevalence of hypertensive crisis is high in our subjects.
Per oral calcium channel blocker and intravenous nitrate are
the most commonly administered medications in the ER and
ward. Acute renal failure is the most common complication
developed in hypertensive crisis.
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